BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/18/2020 5:58:43 AM | Browse: 269 | Download: 327
Publication Name World Journal of Hepatology
Manuscript ID 58668
Country/Territory Australia
2020-08-01 06:59
Peer-Review Started
2020-08-01 07:00
To Make the First Decision
Return for Revision
2020-09-24 16:50
2020-10-08 05:17
Second Decision
2020-10-23 10:58
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-10-26 17:03
Articles in Press
2020-10-26 17:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2020-12-04 08:15
Publish the Manuscript Online
2020-12-18 05:58
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Minireviews
Article Title Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
Manuscript Source Invited Manuscript
All Author List Madeleine G Gill and Avik Majumdar
Author(s) ORCID Number
Madeleine G Gill http://orcid.org/0000-0002-4201-0173
Avik Majumdar http://orcid.org/0000-0003-2975-4327
Funding Agency and Grant Number
Corresponding Author Avik Majumdar, FRACP, MBBS, PhD, Senior Lecturer, Staff Physician, Central Clinical School, The University of Sydney, Camperdown NSW 2006, Sydney 2050, New South Wales, Australia. avik.majumdar@health.nsw.gov.au
Key Words Fatty liver; Metabolic associated fatty liver disease; Non-alcoholic fatty liver disease; Liver transplantation; Cirrhosis; Metabolic syndrome
Core Tip Metabolic Associated Fatty Liver Disease (MAFLD), previously termed non-alcoholic fatty liver disease, is the leading global cause of liver disease and is becoming the most common indication for liver transplantation. Several challenges exist in the pre-, peri-and post-liver transplant setting for patients with MAFLD, which mostly relate to comorbid medical conditions, obesity and cardiovascular risk. Donor liver steatosis is also an increasing concern. In this review, we summarise the current literature and provide an approach to address the current challenges of MAFLD and liver transplantation.
Publish Date 2020-12-18 05:58
Citation Gill MG, Majumdar A. Metabolic associated fatty liver disease: Addressing a new era in liver transplantation. World J Hepatol 2020; 12(12): 1168-1181
URL https://www.wjgnet.com/1948-5182/full/v12/i12/1168.htm
DOI https://dx.doi.org/10.4254/wjh.v12.i12.1168
Full Article (PDF) WJH-12-1168.pdf
Full Article (Word) WJH-12-1168.docx
Manuscript File 58668_Auto_Edited.docx
Answering Reviewers 58668-Answering reviewers.pdf
Audio Core Tip 58668-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 58668-Conflict-of-interest statement.pdf
Copyright License Agreement 58668-Copyright license agreement.pdf
Peer-review Report 58668-Peer-review(s).pdf
Scientific Misconduct Check 58668-Scientific misconduct check.pdf
Scientific Editor Work List 58668-Scientific editor work list.pdf